We are live on ! Find out more
OQS

Occudo Quantitative Strategies Portfolio holdings

AUM $1.84B
1-Year Est. Return 22.15%
This Fund
S&P 500
This Quarter Est. Return
+9.38%
1 Year Est. Return
+22.15%
3 Year Est. Return
+67.4%
5 Year Est. Return
+61.87%
10 Year Est. Return
–
AUM
$572M
AUM Growth
-$164M
Cap. Flow
-$186M
Cap. Flow %
-32.56%
Top 10 Hldgs %
9.94%
Holding
1,089
New
342
Increased
119
Reduced
240
Closed
388

Top Buys

Rank Stock Value
1
ADBE icon
Adobe
ADBE
+$6.26M
2
USB icon
US Bancorp
USB
+$5.75M
3
STX icon
Seagate
STX
+$5.58M
4
META icon
Meta Platforms (Facebook)
META
+$5.42M
5
OTIS icon
Otis Worldwide
OTIS
+$4.51M

Top Sells

Rank Stock Value
1
LYV icon
Live Nation Entertainment
LYV
+$6.03M
2
SNAP icon
Snap
SNAP
+$6.01M
3
INTC icon
Intel
INTC
+$5.99M
4
GTLB icon
GitLab
GTLB
+$5.9M
5
TSLA icon
Tesla
TSLA
+$5.73M

Sector Composition

Rank Sector Weight
1 Technology 28.19%
2 Industrials 18.95%
3 Consumer Discretionary 12.3%
4 Financials 10.08%
5 Healthcare 7.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADMA icon
676
ADMA Biologics
ADMA
$2.07B
$75.6K 0.01%
11,453
-187,368
-94% -$1.02M
RPTX
677
DELISTED
Repare Therapeutics
RPTX
$72.7K 0.01%
15,443
-15,386
-50% -$98.6K
IVAC
678
DELISTED
Intevac Inc
IVAC
$68.1K 0.01%
17,737
-1,318
-7% -$5.28K
BVS icon
679
Bioventus
BVS
$909M
$67.3K 0.01%
12,933
-10,195
-44% -$49.8K
CATO icon
680
Cato Corp
CATO
$66.5M
$64.1K 0.01%
11,114
-1,405
-11% -$9.38K
ABCL icon
681
AbCellera Biologics
ABCL
$1.86B
$61.7K 0.01%
+13,630
New +$69.6K
ARC
682
DELISTED
ARC Document Solutions, Inc.
ARC
$58.2K 0.01%
21,002
-3,130
-13% -$8.84K
ANIX icon
683
Anixa Biosciences
ANIX
$116M
$57.9K 0.01%
+18,554
New +$74K
IPSC icon
684
Century Therapeutics
IPSC
$363M
$56.7K 0.01%
+13,562
New +$57.4K
III icon
685
Information Services Group
III
$210M
$56.4K 0.01%
+13,965
New +$60.6K
CHPT icon
686
ChargePoint
CHPT
$152M
$56K 0.01%
1,473
-494
-25% -$19.4K
BDTX icon
687
Black Diamond Therapeutics
BDTX
$102M
$55.9K 0.01%
11,032
-7,102
-39% -$28.6K
KNTE
688
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$55.7K 0.01%
20,925
-48,888
-70% -$121K
BCOV
689
DELISTED
Brightcove, Inc.
BCOV
$55.6K 0.01%
+28,650
New +$62.9K
CUE icon
690
Cue Biopharma
CUE
$112M
$55K 0.01%
969
-146
-13% -$10.3K
ASYS icon
691
Amtech Systems
ASYS
$305M
$54.5K 0.01%
+10,076
New +$45.4K
ZURA icon
692
Zura Bio
ZURA
$541M
$48.9K 0.01%
19,042
-1,744
-8% -$6.18K
CRNT icon
693
Ceragon Networks
CRNT
$209M
$48.3K 0.01%
+15,106
New +$41.4K
OVID icon
694
Ovid Therapeutics
OVID
$474M
$43K 0.01%
+14,086
New +$47.1K
MKTW icon
695
MarketWise
MKTW
$56.5M
$41.2K 0.01%
1,191
-242
-17% -$10.3K
CNTY icon
696
Century Casinos
CNTY
$34.3M
$36.5K 0.01%
11,551
-2,010
-15% -$6.78K
GERN icon
697
Geron
GERN
$860M
$34.3K 0.01%
+10,393
New +$23.3K
KZR
698
DELISTED
Kezar Life Sciences
KZR
$28.6K 0.01%
3,177
-252
-7% -$2.3K
PRQR icon
699
ProQR Therapeutics
PRQR
$258M
$27.6K ﹤0.01%
+12,053
New +$25.8K
GSAT icon
700
Globalstar
GSAT
$10.8B
$24.7K ﹤0.01%
1,122
-6,944
-86% -$168K
26 27
28
29 30

Similar funds

RP
Regal Partners Sydney, NSW, Australia $1.84B AUM 54.78% 1-Year Est. Return
ABTD
Arvest Bank Trust Division Dewey, Oklahoma $1.84B AUM 20.84% 1-Year Est. Return
KAM
Kensington Asset Management Austin, Texas $1.84B AUM 13.95% 1-Year Est. Return
FCIM
Fairview Capital Investment Management Greenbrae, California $1.84B AUM 13.39% 1-Year Est. Return
CPSAC
Chas P. Smith & Associates (CPS) Lakeland, Florida $1.84B AUM 13.62% 1-Year Est. Return
OFS
OneAscent Financial Services Birmingham, Alabama $1.85B AUM 18.45% 1-Year Est. Return
LOAME
Lombard Odier Asset Management (Europe) London, United Kingdom $1.85B AUM 27.05% 1-Year Est. Return
DP
Dearborn Partners Chicago, Illinois $1.85B AUM 6.59% 1-Year Est. Return

Occudo Quantitative Strategies's Q1 2024 Portfolio in Review

As of Q1 2024, Occudo Quantitative Strategies held 1,089 positions worth $572M, down 22% from $736M the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.

Occudo Quantitative Strategies withdrew a net $186M in Q1 2024, closing 388 positions and reducing 240 holdings. Its most notable exit was Live Nation Entertainment, an estimated $6.03M position sold in full.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 23% a quarter earlier, followed by Industrials and Consumer Discretionary.

Against the trend, Occudo Quantitative Strategies opened a new position in Adobe worth $5.51M.

  • Occudo Quantitative Strategies's largest Q1 2024 buy was Adobe: 10,925 shares worth $5.51M.
  • Occudo Quantitative Strategies added most to T-Mobile US in Q1 2024, an estimated $4.42M increase.
  • Occudo Quantitative Strategies's biggest Q1 2024 reduction was Brown-Forman Class B, cutting an estimated $5.06M.
  • Occudo Quantitative Strategies fully exited Live Nation Entertainment in Q1 2024, selling an estimated $6.03M.
  • Occudo Quantitative Strategies's ten largest holdings make up 9.9% of its $572M portfolio in Q1 2024.
  • Occudo Quantitative Strategies opened 342 new positions and closed 388 in Q1 2024.
  • Occudo Quantitative Strategies's portfolio value fell 22% quarter-over-quarter to $572M.

Based on Occudo Quantitative Strategies's 13F filing for Q1 2024, filed 15 May 2024.